Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Axsome, Cassava, CNS, Genelux, Kezar, Mural, Nanoscope, Newsoara, Oncotelic, Traws.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akeso, Aura, Cel-Sci, CG Oncology, Opthea, Ractigen, Unity.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Calyxo, Nanoscope.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Innovent, Taimed.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Iecure, Opus Genetics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bellaseno, Immunovia.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Briacell, Corvus, Hyloris, Medera, Monte Rosa, Neurocrine, PTC.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allurion Technologies, Angle, Medtronic, Volitionrx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acumen, Benitec, Hutchmed, Immunovant, Innovent, Maat, Novartis, Regenxbio, Roivant, Satellos, Tvardi, UCB.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Establishment Labs, Insulet.